These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26373548)

  • 1. Genetic influence on visual outcomes of polypoidal choroidal vasculopathy.
    Tan CS; Ngo WK; Lim LW; Lim TH
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1019-20. PubMed ID: 26373548
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy.
    Hata M; Tsujikawa A; Yoshimura N
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1021-2. PubMed ID: 26338823
    [No Abstract]   [Full Text] [Related]  

  • 3. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Sakurada Y; Sugiyama A; Tanabe N; Kikushima W; Kume A; Iijima H
    Retina; 2017 Oct; 37(10):1866-1872. PubMed ID: 28002268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy.
    Okubo A; Sameshima M; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):962-5. PubMed ID: 15221299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
    Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
    Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy of polypoidal choroidal vasculopathy.
    Rogers AH; Greenberg PB; Martidis A; Puliafito CA
    Ophthalmic Surg Lasers Imaging; 2003; 34(1):60-3. PubMed ID: 12570008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration.
    Lorentzen TD; Subhi Y; Sørensen TL
    Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral idiopathic polypoidal choroidal vasculopathy].
    Merle H; Donnio A; Jean-Charles A
    Can J Ophthalmol; 2007 Aug; 42(4):631-2. PubMed ID: 17641718
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.
    Morimoto M; Matsumoto H; Mimura K; Akiyama H
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy.
    Tsujikawa A; Ojima Y; Yamashiro K; Nakata I; Ooto S; Tamura H; Nakanishi H; Hayashi H; Otani A; Yoshimura N
    Am J Ophthalmol; 2011 Jun; 151(6):961-972.e1. PubMed ID: 21457926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of ziv-aflibercept for treatment-naïve polypoidal choroidal vasculopathy.
    Chan EW; Eldeeb M; Govindhari V; Sarvaiya C; Banker A; Mansour A; Chhablani J
    Acta Ophthalmol; 2018 Mar; 96(2):e258-e259. PubMed ID: 28926212
    [No Abstract]   [Full Text] [Related]  

  • 12. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic polypoidal choroidal vasculopathy of the macula.
    Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
    Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Chhablani J
    Am J Ophthalmol; 2010 Sep; 150(3):443-4; author reply 444. PubMed ID: 20728684
    [No Abstract]   [Full Text] [Related]  

  • 17. One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Matsumiya W; Honda S; Otsuka K; Miki A; Nagai T; Imai H; Kusuhara S; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):541-548. PubMed ID: 27687988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
    Nishijima K; Takahashi M; Akita J; Katsuta H; Tanemura M; Aikawa H; Mandai M; Takagi H; Kiryu J; Honda Y
    Am J Ophthalmol; 2004 Apr; 137(4):770-3. PubMed ID: 15059729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observation of polypoidal choroidal vasculopathy].
    Zou WJ; Wen F; Wu ZF; Huang SZ; Zhang J; Luo GW
    Zhonghua Yan Ke Za Zhi; 2011 Jan; 47(1):39-44. PubMed ID: 21418926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma.
    Mauget-Faÿsse M; Cornut PL; Quaranta El-Maftouhi M; Leys A
    Am J Ophthalmol; 2006 Dec; 142(6):970-5. PubMed ID: 17046703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.